TARO 16 (Carbamazepine (Chewable) 100 mg)
Pill with imprint TARO 16 is White, Round and has been identified as Carbamazepine (Chewable) 100 mg. It is supplied by Taro Pharmaceuticals U.S.A., Inc..
Carbamazepine is used in the treatment of trigeminal neuralgia; schizoaffective disorder; bipolar disorder; epilepsy and belongs to the drug class dibenzazepine anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Carbamazepine 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TARO 16




Carbamazepine (Chewable)
- Imprint
- TARO 16
- Strength
- 100 mg
- Color
- White
- Size
- 11.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Dibenzazepine anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Taro Pharmaceuticals U.S.A., Inc.
- Inactive Ingredients
-
croscarmellose sodium, diethyl phthalate, FD&C Red No. 40, aluminum oxide, magnesium stearate, microcrystalline cellulose, corn starch, sorbitol
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
51672-4041 | Taro Pharmaceuticals USA, Inc. |
49999-0782 | Lake Erie Medical and Surgical Supply (repackager) |
54569-2795 | A-S Medication Solutions, LLC (repackager) |
Related Images for "TARO 16"
More about carbamazepine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- 287 Reviews
- Drug class: dibenzazepine anticonvulsants
- FDA Alerts (2)
Consumer resources
- Carbamazepine
- Carbamazepine (Advanced Reading)
- Carbamazepine Intravenous (Advanced Reading)
- Carbamazepine Chewable Tablets
- Carbamazepine Extended-Release Capsules (Carbatrol)
- ... +4 more
Other brands: Tegretol, Carbatrol, Equetro, Tegretol XR, ... +2 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.